X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6609) 6609
Book Review (934) 934
Publication (448) 448
Book Chapter (25) 25
Conference Proceeding (13) 13
Presentation (2) 2
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5156) 5156
ophthalmology (4864) 4864
humans (4762) 4762
bevacizumab (3358) 3358
intravitreal injections (3196) 3196
male (3192) 3192
female (3090) 3090
ranibizumab (2388) 2388
aged (2352) 2352
vascular endothelial growth factor a - antagonists & inhibitors (2270) 2270
middle aged (2144) 2144
macular degeneration (2029) 2029
angiogenesis inhibitors - therapeutic use (1770) 1770
angiogenesis inhibitors - administration & dosage (1665) 1665
tomography, optical coherence (1635) 1635
treatment outcome (1492) 1492
intravitreal bevacizumab (1490) 1490
endothelial growth-factor (1462) 1462
vascular endothelial growth factor (1430) 1430
retrospective studies (1402) 1402
fluorescein angiography (1340) 1340
aged, 80 and over (1327) 1327
eye diseases (1208) 1208
visual acuity (1206) 1206
visual acuity - physiology (1169) 1169
follow-up studies (1109) 1109
adult (949) 949
intravitreal injection (944) 944
diabetic retinopathy (943) 943
genetic structures (941) 941
macular edema - drug therapy (871) 871
prospective studies (821) 821
photodynamic therapy (815) 815
injection (803) 803
choroidal neovascularization (801) 801
optical coherence tomography (795) 795
antibodies, monoclonal, humanized - therapeutic use (766) 766
care and treatment (766) 766
choroidal neovascularization - drug therapy (765) 765
retina (759) 759
antibodies, monoclonal, humanized (757) 757
antibodies, monoclonal, humanized - administration & dosage (734) 734
sense organs (724) 724
macular edema (714) 714
neovascularization (678) 678
age-related macular degeneration (672) 672
therapy (652) 652
wet macular degeneration - drug therapy (635) 635
edema (633) 633
avastin (630) 630
macular degeneration - drug therapy (618) 618
diabetic retinopathy - drug therapy (572) 572
retinopathy (568) 568
medicine & public health (567) 567
animals (564) 564
diabetes (517) 517
diabetic macular edema (509) 509
angiogenesis inhibitors - adverse effects (492) 492
analysis (478) 478
macular edema - etiology (474) 474
vegf (456) 456
surgery (454) 454
verteporfin (454) 454
physiological aspects (451) 451
triamcinolone (440) 440
drug therapy (436) 436
research (433) 433
degeneration (432) 432
time factors (427) 427
antibodies, monoclonal - administration & dosage (419) 419
risk factors (411) 411
pharmacology & pharmacy (409) 409
age (406) 406
vitrectomy (404) 404
aflibercept (402) 402
eye (402) 402
patients (395) 395
injections (388) 388
bevacizumab - administration & dosage (383) 383
retinal vein occlusion (374) 374
retina - pathology (373) 373
efficacy (370) 370
fundus oculi (370) 370
anti-vegf (368) 368
triamcinolone acetonide (367) 367
abridged index medicus (362) 362
antibodies, monoclonal - therapeutic use (361) 361
safety (360) 360
visual acuity - drug effects (357) 357
ranibizumab - administration & dosage (351) 351
retinal vein occlusion - drug therapy (347) 347
bevacizumab - therapeutic use (341) 341
choroidal neovascularization - etiology (341) 341
secondary (340) 340
angiogenesis (336) 336
ranibizumab - therapeutic use (330) 330
intravitreal bevacizumab avastin (325) 325
macular edema - diagnosis (321) 321
studies (321) 321
macular edema - physiopathology (316) 316
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6116) 6116
German (197) 197
French (98) 98
Korean (95) 95
Spanish (43) 43
Turkish (27) 27
Portuguese (13) 13
Japanese (11) 11
Polish (8) 8
Romanian (6) 6
Czech (3) 3
Chinese (2) 2
Russian (2) 2
Slovenian (2) 2
Swedish (2) 2
Hungarian (1) 1
Italian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 11/2014, Volume 132, Issue 11, pp. 1327 - 1333
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 13, pp. 1193 - 1203
Journal Article
Cancer, ISSN 0008-543X, 12/2013, Volume 119, Issue 23, pp. 4180 - 4187
Journal Article
Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 1/2008, Volume 246, Issue 1, pp. 81 - 87
Vascular endothelial growth factor (VEGF) plays an important role in many diseases of the posterior pole that are characterized by macular edema and/or... 
Angiogenesis | Intravitreal bevacizumab | Medicine & Public Health | Choroidal neovascularization | Age-related macular degeneration | Proliferative diabetic retinopathy | Diabetic macular edema | Ophthalmology | Safety | intravitreal bevacizumab | PHOTODYNAMIC THERAPY | choroidal neovascularization | angiogenesis | COHERENCE TOMOGRAPHY FINDINGS | BARRIER | MACULAR DEGENERATION | VERTEPORFIN | PHARMACOKINETICS | safety | PEGAPTANIB | GROWTH-FACTOR APTAMER | OPHTHALMOLOGY | age-related macular degeneration | proliferative diabetic retinopathy | diabetic macular edema | SUBFOVEAL CHOROIDAL NEOVASCULARIZATION | BREAKDOWN | Diabetic Retinopathy - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Macular Degeneration - drug therapy | Bevacizumab | Diabetic Retinopathy - physiopathology | Antibodies, Monoclonal, Humanized | Choroidal Neovascularization - drug therapy | Time Factors | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Vitreous Body | Adult | Female | Retrospective Studies | Angiogenesis Inhibitors - adverse effects | Retinal Vein Occlusion - physiopathology | Macular Degeneration - physiopathology | Treatment Outcome | Visual Acuity | Choroidal Neovascularization - physiopathology | Retreatment | Injections | Retinal Vein Occlusion - drug therapy | Macular Edema - physiopathology | Macular Edema - drug therapy | Aged | Endothelial growth factors | Safety and security measures | Angiogenesis inhibitors | Index Medicus
Journal Article
Ophthalmology, ISSN 0161-6420, 2012, Volume 119, Issue 7, pp. 1399 - 1411
Purpose To compare the efficacy and safety of ranibizumab and bevacizumab intravitreal injections to treat neovascular age-related macular degeneration (nAMD).... 
Ophthalmology | DIABETIC-RETINOPATHY | TRIAL | AVASTIN | DESIGN | OPHTHALMOLOGY | INTRAVITREAL BEVACIZUMAB | CHARTS | Macular degeneration | Chronic diseases | Angiogenesis inhibitors | Universities and colleges
Journal Article